Nevertheless, the conjugates of GnRH-II and GnRH-III proved to have a comparable antitumor effect; moreover, they have been indicated to possess higher tumor selectivity and stability than that the GnRH-I-based conjugate [12,21,37,38]. This evidence concerns the gene GNRH1 and neoplasm.